Adjuvant chemotherapy is recommended, or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer
Percentage of patients, age = 18 and < 80 at diagnosis, who have their first diagnosis of cancer (epithelial malignancy) that is lymph node positive and at AJCC stage III, whose primary tumor is of the colon and chemotherapy was recommended or administered within 4 months (120 days) of diagnosis
Adjuvant chemotherapy is administered within 4 months (120 days) of the date of diagnosis or it is recommended but not administered
Denominator
1.15 Denominator
Include if all of the following characteristics are identified: Men or Women Age = 18 and < 80 at time of diagnosis Known or assumed to be first or only cancer diagnosis Epithelial malignancy only Invasive tumors Primary tumors of the colon All or part of 1st course of treatment performed at the reporting facility Known to be alive within 4 months (120 days) of date of diagnosis Lymph node positive disease Surgical procedure of the primary site
Exclusions
Exclusions
Exclude, if any of the following characteristics are identified: Under age 18 or over age 80 at time of diagnosis Second or subsequent cancer diagnosis Tumor not originating in the colon Non-epithelial malignancies Non-invasive tumors Stage 0, in situ tumor Stage IV, metastatic tumor None of 1st course therapy performed at reporting facility Died within 4 months (120 days) of diagnosis Not lymph node positive disease Patient enrolled in a clinical trial that directly impacts delivery of the standard of care No surgical procedure of the primary site
Public Comments